Atlas Trials

Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy

Clinical trial NCT02679105 · COMPLETED

Trial details

NCT number
NCT02679105
Sponsor
Karolinska Institutet
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Rhinitis, Allergic
Start date
2015-05-01
Primary completion
2016-10-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.